Generate a tailored SOP for Dr. Roderick Slavcev. Improve your application with a focused, well-structured draft.
Roderick Slavcev is an Associate Professor at the University of Waterloo's School of Pharmacy. His research specializes in bacteriophage-based biotechnology, focusing on phage genetic systems and the generation of novel therapeutic platforms. In particular, Slavcev’s lab engages in designing and constructing vectors for vaccines, gene delivery systems, and immunotherapeutics, while also identifying and applying novel phage genomic anti-bacterial genes for potential phage therapy applications. His multidisciplinary lab integrates various fields including genetics, molecular biology, microbiology, gene therapy, virology, and synthetic biology. He has held positions such as Chief Technology Officer at Mediphage Bioceuticals, Inc., and Principal Investigator at the Centre for Eye Vision Research in Hong Kong. Slavcev is active in academic and industrial research, with numerous publications showcasing his contributions to drug discovery, oncology, and vaccine design. He is a member of various professional associations, such as the American Society for Gene and Cell Therapy, and he has won several awards for his innovative research in the field.
Mediphage Bioceuticals, Inc. • MaRS Toronto
Leading technology development and research initiatives.
Centre for Eye Vision Research • Hong Kong Science and Technology Park
Overseeing research projects in eye health and vision science.
A patent related to the production of virus-like particles.
Patent for a system that produces DNA vectors.
Includes fields like Clinical, Cognitive, Developmental, and Industrial/Organizational Psychology.